NCT00001041View on ClinicalTrials.gov

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1998

Conditions

HIV InfectionsPregnancy

Interventions

BIOLOGICAL

rgp120/HIV-1MN

Trial Locations (6)

14642

Univ. of Rochester ACTG CRS, Rochester

63104

Washington U CRS, St Louis

63112

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

212874933

Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases, Baltimore

941102859

San Francisco Gen. Hosp., San Francisco

Unknown

UCSF Pediatric AIDS CRS, San Francisco

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001041 - Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo) | Biotech Hunter | Biotech Hunter